Executive Summary

Oct 2019
PROSPECTS
Concerned parents seek treatment advice for head lice from pharmacists supporting stable demand for antiparasitics/lice (head and body) treatments

Dermatologicals recorded positive current value growth, with ongoing demand for a number of products including medicated shampoos, antiparasitics/lice (head and body) treatments, and haemorrhoid treatments. Antiparasitics/lice (head and body) treatments is supported by the rising incidence of head lice during the past decade, mainly experienced by children between 3-11 years.

Mild recovery for antipruritics supported by increasing cases of atopic eczema

Demand for antipruritics stabilised after several years of low decline, supported by cases of atopic eczema which are increasing amongst younger Swedes, affecting approximately 20% of children. The inflammation caused by dermatitis can be treated with mild cortisone products and prevented with other antipruritic creams.

Ongoing declining demand for nappy (diaper) rash treatments with parents looking to natural and organic products

Demand for OTC nappy (diaper) rash treatments continued to decline as Swedish parents become increasingly concerned about the types of paediatric products that they use on young children. This has led to premiumisation in paediatric products with parents increasingly turning towards natural and organic products, further hampering the growth of nappy (diaper) rash treatments and paediatric dermatologicals in 2019.

COMPETITIVE LANDSCAPE
Trimb Healthcare retains leadership with strength across number of categories

Trimb Healthcare retained its leadership of overall dermatologicals in 2019 due to the strong positions of its antipruritics brands Hydrokortison CCS and Propyless. In the current state of dermatologicals, with a low level of product innovation and few new entries, the main way to increase share is acquisition, a strategy the player followed over the review period.

Intense competition within antiparasitics/lice (head and body) treatments leading to some movement

Competition remained intense in the highly fragmented landscape of antiparasitics/lice (head and body) treatments, where the share of “others” is high, although marginally declining. While Paranix from Perrigo Sverige AB retained its leadership, Meda’s Linicin moved up into second position gaining strong value share from rival Hedrin (Mundipharma) and recording another year of impressive current value growth.

Premium skin care can offer competition with blurring of boundaries

Premium skin care brands such as La Roche-Posay are blurring the boundaries with some dermatologicals, offering competition outside of the category, particularly as these products are finding their way into pharmacies in Sweden, which increases consumer acceptance of these products and also further exacerbates the competition with dermatologicals. While pharmacists still recommend OTC dermatologicals to treat serious medical problems, products such as La Roche-Posay’s gentle body wash Lipikar Syndet AP+ or its emollient Lipikar Baume AP+ are marketed as being suitable to address very dry skin problems including eczema, which may attract some consumers who read online reviews or brands’ websites.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Sweden

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Sweden with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Sweden, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Sweden market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Sweden?
  • What are the major brands in Sweden?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Sweden - Category analysis

HEADLINES

PROSPECTS

Concerned parents seek treatment advice for head lice from pharmacists supporting stable demand for antiparasitics/lice (head and body) treatments
Mild recovery for antipruritics supported by increasing cases of atopic eczema
Ongoing declining demand for nappy (diaper) rash treatments with parents looking to natural and organic products

COMPETITIVE LANDSCAPE

Trimb Healthcare retains leadership with strength across number of categories
Intense competition within antiparasitics/lice (head and body) treatments leading to some movement
Premium skin care can offer competition with blurring of boundaries

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Sweden - Industry Overview

EXECUTIVE SUMMARY

Stable performance by consumer health supported by health and wellness trends
Vegans offer growing niche as important consumer group
Highly fragmented competitive landscape of consumer health allows smaller brands to gain Swedes’ attention
Internet retailing continues to gain ground supported by online pharmacies
Sports nutrition will continue to move into mainstream acceptance over forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources